Elena Verri
Papers
1
Total Citations
8
H-Index
1
About
Elena Verri is a leading urologic oncology researcher whose work centers on optimizing treatment strategies for advanced prostate cancer, particularly oligometastatic disease. Her major contribution lies in challenging the standard of care by demonstrating the superiority of multimodality treatment over androgen deprivation therapy alone. Her landmark 2022 study, which has garnered 8 citations, compared robot-assisted radical prostatectomy combined with ADT—with or without adjuvant radiotherapy—against ADT monotherapy in oligometastatic prostate cancer patients. This work provides compelling evidence that aggressive local control through surgery can improve outcomes in this traditionally palliative setting. Verri’s research sits at the intersection of surgical innovation and precision oncology, helping to redefine which patients benefit from intensified therapy. Her findings have significant implications for clinical decision-making, offering a roadmap for personalized treatment in metastatic disease. By systematically evaluating real-world outcomes from 2010 to 2018, Verri has established herself as a key voice in the ongoing debate about the role of cytoreductive surgery in oligometastatic prostate cancer, influencing both urologists and oncologists.
Research Focus
Key Achievements
Top Papers
- 1